Wilcock GK - Search Results

1

APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease.

Chalmers KA, Culpan D, Kehoe PG, Wilcock GK, Hughes A, Love S. Chalmers KA, et al. Among authors: wilcock gk. Neuroreport. 2004 Jan 19;15(1):95-8. doi: 10.1097/00001756-200401190-00019. Neuroreport. 2004. PMID: 15106838

2

Neither sequence variation in the IL-10 gene promoter nor presence of IL-10 protein in the cerebral cortex is associated with Alzheimer's disease.

Culpan D, Prince JA, Matthews S, Palmer L, Hughes A, Love S, Kehoe PG, Wilcock GK. Culpan D, et al. Among authors: wilcock gk. Neurosci Lett. 2006 Nov 13;408(2):141-5. doi: 10.1016/j.neulet.2006.08.068. Epub 2006 Sep 14. Neurosci Lett. 2006. PMID: 16973274

3

Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease.

Culpan D, Cornish A, Love S, Kehoe PG, Wilcock GK. Culpan D, et al. Among authors: wilcock gk. Exp Gerontol. 2007 Jun;42(6):538-44. doi: 10.1016/j.exger.2006.12.001. Epub 2007 Jan 30. Exp Gerontol. 2007. PMID: 17267158

4

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?

Kehoe PG, Wilcock GK. Kehoe PG, et al. Among authors: wilcock gk. Lancet Neurol. 2007 Apr;6(4):373-8. doi: 10.1016/S1474-4422(07)70077-7. Lancet Neurol. 2007. PMID: 17362841 Review.

5

TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease.

Culpan D, Cram D, Chalmers K, Cornish A, Palmer L, Palmer J, Hughes A, Passmore P, Craig D, Wilcock GK, Kehoe PG, Love S. Culpan D, et al. Among authors: wilcock gk. Neurobiol Aging. 2009 Jul;30(7):1052-60. doi: 10.1016/j.neurobiolaging.2007.10.014. Epub 2007 Dec 11. Neurobiol Aging. 2009. PMID: 18069092

6

Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease.

Culpan D, MacGowan SH, Ford JM, Nicoll JA, Griffin WS, Dewar D, Cairns NJ, Hughes A, Kehoe PG, Wilcock GK. Culpan D, et al. Among authors: wilcock gk. Neurosci Lett. 2003 Oct 16;350(1):61-5. doi: 10.1016/s0304-3940(03)00854-1. Neurosci Lett. 2003. PMID: 12962917

7

APOE and cerebral amyloid angiopathy in the elderly.

Love S, Nicoll JA, Hughes A, Wilcock GK. Love S, et al. Among authors: wilcock gk. Neuroreport. 2003 Aug 6;14(11):1535-6. doi: 10.1097/00001756-200308060-00027. Neuroreport. 2003. PMID: 12960780

8

Contributors to white matter damage in the frontal lobe in Alzheimer's disease.

Chalmers K, Wilcock G, Love S. Chalmers K, et al. Neuropathol Appl Neurobiol. 2005 Dec;31(6):623-31. doi: 10.1111/j.1365-2990.2005.00678.x. Neuropathol Appl Neurobiol. 2005. PMID: 16281911

9

Premorbid effects of APOE on synaptic proteins in human temporal neocortex.

Love S, Siew LK, Dawbarn D, Wilcock GK, Ben-Shlomo Y, Allen SJ. Love S, et al. Among authors: wilcock gk. Neurobiol Aging. 2006 Jun;27(6):797-803. doi: 10.1016/j.neurobiolaging.2005.04.008. Epub 2005 Jun 23. Neurobiol Aging. 2006. PMID: 15979210

10

Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease.

Baig S, Wilcock GK, Love S. Baig S, et al. Among authors: wilcock gk. Acta Neuropathol. 2005 Oct;110(4):393-401. doi: 10.1007/s00401-005-1060-2. Epub 2005 Aug 30. Acta Neuropathol. 2005. PMID: 16133543

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

240 results

Search Page